Khayyat Yasir Mohammed
Department of Medicine, Faculty of Medicine, Umm Al-Qura University, Makkah, Al-Awali District, 24381 - 8156, Saudi Arabia.
Ther Adv Gastrointest Endosc. 2022 Feb 4;15:26317745211073411. doi: 10.1177/26317745211073411. eCollection 2022 Jan-Dec.
Percutaneous cecostomy is a minimally invasive procedure that provides access to the colon for therapeutic interventions. This review aimed to update and summarize the existing information on the use and application of percutaneous endoscopic cecostomy in the field of therapeutic gastroenterology.
A systematic review of the literature was performed without any restrictions on the year of publication from the date of inception in 1986 to January 2021.
The review was performed using the medical subject heading keywords in the following search engines: MEDLINE, EMBASE, Cochrane, and Google Scholar.
A total of 29 articles were subjected to final data extraction. The review included a total of 174 patients who underwent percutaneous cecostomy. Most of the included studies were conducted in the United States ( = 14). The most common comorbidity was cancer ( = 10) and the major indication for performing percutaneous cecostomy was colonic pseudo-obstruction or Ogilvie's syndrome ( = 15). The main technique for performing percutaneous cecostomy was endoscopy (17 studies), followed by fluoroscopy- (five studies), computed-tomography- (three studies), laparoscopy- (two studies), and ultrasound- (one study) guided procedures. The procedure was technically successful in 153 (88%) cases. The total cumulative rates of major and minor complications were 47.5%. These complications included tube malfunction, local wound site infections, and bleeding and rare complications of peritonitis and death.
Percutaneous cecostomy is a safe and effective option for managing acute colonic pseudo-obstruction. It leads to durable symptom relief with low to minimal risk.
经皮盲肠造口术是一种微创手术,可为治疗性干预提供进入结肠的途径。本综述旨在更新和总结经皮内镜盲肠造口术在治疗性胃肠病学领域的使用和应用的现有信息。
对文献进行系统综述,对1986年开始至2021年1月的发表年份没有任何限制。
使用以下搜索引擎中的医学主题词关键词进行综述:医学文献数据库(MEDLINE)、荷兰医学文摘数据库(EMBASE)、考克兰图书馆(Cochrane)和谷歌学术。
共有29篇文章进行了最终数据提取。该综述共纳入174例行经皮盲肠造口术的患者。纳入的研究大多在美国进行(n = 14)。最常见的合并症是癌症(n = 10),行经皮盲肠造口术的主要指征是结肠假性梗阻或奥吉尔维综合征(n = 15)。行经皮盲肠造口术的主要技术是内镜引导(17项研究),其次是透视引导(5项研究)、计算机断层扫描引导(3项研究)、腹腔镜引导(2项研究)和超声引导(1项研究)的操作。该操作在153例(88%)病例中技术成功。主要和次要并发症的总累积发生率为47.5%。这些并发症包括导管故障、局部伤口部位感染、出血以及罕见的腹膜炎和死亡并发症。
经皮盲肠造口术是治疗急性结肠假性梗阻的一种安全有效的选择。它能带来持久的症状缓解,风险低至最小。